The Real World Evidence Revolution
We focus on pragmatic Real-World Evidence (RWE) studies for generating clinically meaningful meaningful data and physician experience faster, unlocking the true potential of these transformational therapies sooner.
We believe it’s the best way to ensure rapid, safe and appropriate access to reimbursed psilocybin therapy.
1 Billion people suffer worldwide
from anxiety and depression disorders worldwide [2]
Costs $1 trillion/yr globally
depression and anxiety, cost the global economy $1 trillion each year [3]
13% Rise in mental health conditions
in mental health conditions and substance use disorders in the last decade [4]
Driving positive mental health change
Psilocybin-based medicines could change the way mental health is treated, and as a result, we believe the human experience as a whole will improve.
Current mental health treatments are decades old, relatively ineffective and can come with severe side effects. New approaches to antidepressants have failed, and major pharma has abandoned R&D in CNS research. [1]